Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute ...

Patients suffering from myocardial infarction who receive early add-on lipid-lowering medication have a significantly better ...

Patients with gout living in rural vs urban areas face a significantly higher risk for MI-related hospitalization.

Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute event.

SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

Adding ezetimibe (Zetia) therapy to statins early after a heart attack improved outcomes, Swedish national records suggested.

The new clinical guide reveals gender-specific cardiovascular risks and prevention strategies for women across all life ...

The direct oral anticoagulant is an effective alternative to warfarin that offers predictable dosing without the need for ...

The following is a summary of "Clinical Characteristics and Outcomes Stratified by Time to ST-Segment Elevation Myocardial Infarction Presentation," published in the March 2025 issue of American ...

Researchers sought to determine the effect of COPD exacerbation risk for ASCVD hospitalization in patients with ASCVD.

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all, new research suggests.